Nonspecific inhibitor released by T acceptor cells reduces the production of interleukin-2
- 1 December 1982
- journal article
- Published by Springer Nature in Nature
- Vol. 300 (5893), 652-655
- https://doi.org/10.1038/300652a0
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses.The Journal of Experimental Medicine, 1982
- Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.The Journal of Experimental Medicine, 1982
- Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines.The Journal of Experimental Medicine, 1979
- T-T-cell interactions during the vitro cytotoxic allograft responses. I. Soluble products from activated Lyl+ T cells trigger autonomously antigen-primed Ly23+ T cells to cell proliferation and cytolytic activity.The Journal of Experimental Medicine, 1978
- Long term culture of tumour-specific cytotoxic T cellsNature, 1977
- Hybrid cell lines with T-cell characteristicsNature, 1977
- Selective in Vitro Growth of T Lymphocytes from Normal Human Bone MarrowsScience, 1976
- Fusion between immunoglobulin‐secreting and nonsecreting myeloma cell linesEuropean Journal of Immunology, 1976
- A rapid method for the isolation of functional thymus‐derived murine lymphocytesEuropean Journal of Immunology, 1973
- AN EXTENSION OF THE51Cr-RELEASE ASSAY FOR THE ESTIMATION OF MOUSE CYTOTOXINSTransplantation, 1968